mRNA editing, Innovative modality of Therapeutics
A new and innovative modality for new medicines: the world's first clinical trial of mRNA editing technology has been approved in the USA. It could be gospel for diseases that have been untreatable due to numerous mutations or large genetic variations.
https://miyata-bio.net/column/0000317/
この記事が気に入ったらサポートをしてみませんか？